Guofang Chen Selected Research

Guofang Chen Research Topics

Disease

8	Stroke (Strokes) 01/2022 - 04/2016
8	Neoplasms (Cancer) 10/2021 - 02/2010
7	Ischemic Stroke 01/2022 - 04/2016
6	Body Weight (Weight, Body) 01/2022 - 01/2016
4	Hypertension (High Blood Pressure) 01/2022 - 01/2018
4	Insulin Resistance 01/2022 - 01/2016
4	Hypoxia (Hypoxemia) 01/2022 - 09/2014
4	Thyroid Neoplasms (Thyroid Cancer) 01/2019 - 04/2012
3	Endometrial Neoplasms (Endometrial Cancer) 03/2022 - 09/2020
3	Type 2 Diabetes Mellitus (MODY) 01/2022 - 12/2014
3	Cerebral Hemorrhage 01/2021 - 06/2016
2	Hemorrhage 01/2022 - 04/2016
2	Obesity 01/2022 - 01/2022
2	Inflammation (Inflammations) 01/2022 - 01/2016
2	Diabetes Mellitus 01/2020 - 01/2018
2	Glucose Intolerance 11/2019 - 01/2019
2	Hypothyroidism 01/2019 - 01/2018
2	Goiter 01/2017 - 04/2012
2	Carcinoma (Carcinomatosis) 05/2015 - 04/2012
2	Anaplastic Thyroid Carcinoma 04/2015 - 04/2012
1	Transient Ischemic Attack 01/2022
1	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2022
1	Overweight 01/2022
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 05/2021
1	Gliosis 05/2021
1	Multiple Sclerosis 05/2021
1	Demyelinating Diseases (Demyelinating Disease) 05/2021
1	Spinal Injuries (Spinal Injury) 05/2021
1	Lymphatic Metastasis 01/2021
1	Atrial Fibrillation 01/2020
1	Alzheimer Disease (Alzheimer's Disease) 01/2020
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2019
1	DiGeorge Syndrome (Syndrome, DiGeorge) 01/2019
1	Hyperthyroidism 01/2018
1	Graves Disease (Basedow Disease) 01/2018
1	Thyroid Nodule (Nodule, Thyroid) 01/2017
1	Thyroid Diseases (Thyroid Disease) 01/2017
1	Hyponatremia 07/2016

Drug/Important Bio-Agent (IBA)

7	Insulin (Novolin)FDA Link 01/2022 - 04/2012
6	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2022 - 04/2016
5	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2014
4	Triglycerides (Triacylglycerol)IBA 01/2022 - 11/2019
4	Blood Glucose (Blood Sugar)IBA 01/2022 - 04/2016
3	Warfarin (Coumadin)FDA LinkGeneric 01/2021 - 04/2016
3	Metformin (Glucophage)FDA LinkGeneric 01/2017 - 04/2012
3	Pharmaceutical PreparationsIBA 09/2014 - 04/2012
2	RNA (Ribonucleic Acid)IBA 03/2022 - 10/2021
2	CholesterolIBA 01/2022 - 06/2021
2	Sirtuin 1IBA 01/2022 - 11/2019
2	Vitamin D FDA LinkGeneric 01/2022 - 01/2022
2	hydroxide ionIBA 01/2022 - 01/2022
2	Long Noncoding RNAIBA 05/2021 - 01/2019
2	Thyroid HormonesIBA 01/2019 - 01/2018
2	IodineIBA 01/2018 - 04/2015
2	LipidsIBA 01/2016 - 01/2014
2	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2015 - 04/2012
1	Immune Checkpoint InhibitorsIBA 03/2022
1	Cytochrome P-450 CYP2C19IBA 01/2022
1	oxidized low density lipoproteinIBA 01/2022
1	25-hydroxyvitamin DIBA 01/2022
1	Clopidogrel (Plavix)FDA Link 01/2022
1	TicagrelorIBA 01/2022
1	Antihypertensive Agents (Antihypertensives)IBA 01/2022
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022
1	Hemoglobins (Hemoglobin)IBA 01/2022
1	HDL CholesterolIBA 01/2022
1	LDL CholesterolIBA 01/2022
1	Testosterone (Sustanon)FDA Link 01/2022
1	Uric Acid (Urate)IBA 08/2021
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 05/2021
1	ChemokinesIBA 05/2021
1	Interleukin-9 (Interleukin 9)IBA 05/2021
1	CytokinesIBA 05/2021
1	Messenger RNA (mRNA)IBA 09/2020
1	cinepazideIBA 07/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	Peptides (Polypeptides)IBA 01/2020
1	Amyloid (Amyloid Fibrils)IBA 01/2020
1	gegenqinlianIBA 11/2019
1	CateninsIBA 01/2019
1	Propylthiouracil FDA Link 01/2019
1	Cadherins (E-Cadherin)IBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2019
1	polydatinIBA 01/2019
1	Beclin-1IBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	Antithyroid Agents (Antithyroid Drugs)IBA 01/2018
1	SodiumIBA 07/2016

Therapy/Procedure

6	Therapeutics 03/2022 - 01/2014
2	Immunotherapy 03/2022 - 01/2022
2	Contraindications 01/2019 - 01/2018
1	Caloric Restriction 01/2022
1	Thyroidectomy 01/2021
1	Critical Care (Surgical Intensive Care) 01/2021
1	Activities of Daily Living (ADL) 07/2020
1	Intravenous Infusions 07/2020
1	Thrombolytic Therapy 06/2016
1	Aftercare (After-Treatment) 04/2016